MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss ...

InflaRx to prioritize izicopan as its leading pipeline asset, with a goal of continuing toward Phase 2b readiness in ...

Brits have been told to seek medical treatment immediately if they are bitten by their pet, after one dad was left with a rotting finger from a cat bite. Owning a pet is said to reduce your risk of ...

Brits have been told to seek medical treatment immediately if they are bitten by their pet, after one dad was left with a rotting finger from a cat bite. Owning a pet is said to reduce your risk of ...

MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical evidence strategy for submission of a Biologic License Applic ...

Fishing duo Cole and Jay cast net a draining lake and can’t believe the results. Investigators seize luxury goods over alleged fraud Thousands could lose Medicare gap coverage next month after insurer ...

Are your interactions leaving others exhausted? Here’s how you might be draining the people around you and what to do about it. Most people know what it feels like to be emotionally drained by someone ...

When ET phones home, it could be his last call. Contrary to sci-fi movie depictions, our first contact might not be with a super advanced alien civilization at the height of power. Rather, Ivy League ...

Zach began writing for CNET in November, 2021 after writing for a broadcast news station in his hometown, Cincinnati, for five years. You can usually find him reading and drinking coffee or watching a ...

Microbes are little alchemists that perform all manner of chemical reactions. A team of microbiologists co-founded a ...

Blockchain investigation firm TRM Labs says ongoing cryptocurrency thefts have been traced to the 2022 LastPass breach, with attackers draining wallets years after encrypted vaults were stolen and ...

Arrowhead Pharmaceuticals, Inc. today announced interim results from two Phase 1/2a clinical trials of ARO-INHBE and ARO-ALK7, the company's investigational RNA interference (RNAi) therapeutics being ...